Bio Green Med Solution, Inc. - Asset Resilience Ratio
Bio Green Med Solution, Inc. (BGMS) has an Asset Resilience Ratio of 0.51% as of December 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2017)
This chart shows how Bio Green Med Solution, Inc.'s Asset Resilience Ratio has changed over time. See Bio Green Med Solution, Inc. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Bio Green Med Solution, Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Bio Green Med Solution, Inc. worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $132.00K | 0.51% |
| Total Liquid Assets | $132.00K | 0.51% |
Asset Resilience Insights
- Limited Liquidity: Bio Green Med Solution, Inc. maintains only 0.51% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Bio Green Med Solution, Inc. Industry Peers by Asset Resilience Ratio
Compare Bio Green Med Solution, Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND |
Biotechnology | 0.00% |
|
ALTEOGEN Inc
KQ:196170 |
Biotechnology | 55.57% |
|
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
Biotechnology | 47.01% |
|
Definium Therapeutics, Inc.
NASDAQ:DFTX |
Biotechnology | 34.94% |
|
Neuren Pharmaceuticals Ltd
AU:NEU |
Biotechnology | 90.43% |
|
Galapagos N.V.
AS:GLPG |
Biotechnology | 86.45% |
|
Blue Jet Healthcare Limited
NSE:BLUEJET |
Biotechnology | 13.81% |
|
Inventiva S.A
PA:IVA |
Biotechnology | 52.73% |
Annual Asset Resilience Ratio for Bio Green Med Solution, Inc. (2005–2017)
The table below shows the annual Asset Resilience Ratio data for Bio Green Med Solution, Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.51% | $132.00K | $26.00 Million | -0.16pp |
| 2016-12-31 | 0.67% | $132.00K | $19.66 Million | +0.14pp |
| 2015-12-31 | 0.53% | $132.00K | $24.76 Million | +0.08pp |
| 2014-12-31 | 0.45% | $132.00K | $29.39 Million | -63.22pp |
| 2012-12-31 | 63.67% | $12.32 Million | $19.35 Million | -12.85pp |
| 2011-12-31 | 76.52% | $19.89 Million | $26.00 Million | -15.87pp |
| 2010-12-31 | 92.39% | $29.07 Million | $31.46 Million | +33.66pp |
| 2009-12-31 | 58.74% | $8.50 Million | $14.47 Million | -9.56pp |
| 2008-12-31 | 68.29% | $21.14 Million | $30.96 Million | -1.98pp |
| 2007-12-31 | 70.27% | $53.34 Million | $75.91 Million | +16.12pp |
| 2006-12-31 | 54.15% | $34.26 Million | $63.28 Million | -1.90pp |
| 2005-12-31 | 56.05% | $10.69 Million | $19.07 Million | -- |
About Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green M… Read more